A Cannabis Drug Just Beat Opioids in a Clinical Trial. Here’s What That Means.

The Cannigma
By The Cannigma TeamJun 17, 2026, 2:17 am
For the first time in modern medicine, a cannabis-derived pharmaceutical has received regulatory approval in Europe — and it didn’t just prove effective. It outperformed opioids. On June 9, 2026, VERTANICAL, a biopharmaceutical company headquartered in Munich, Germany, announced that its drug Exilby® (VER-01)…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Marijuana Moment Takes Ask For Rescheduling Hearing Livestreaming Directly To DEA Head After Judge Says He Won’t Consider Request 75

Trump Admin Asks Congress to Regulate Full-Spectrum Hemp Products or Delay Federal Crackdown 73

The Compliance Gap Most Operators Don’t See Coming 68

Louisiana Bill To Create Psychedelic Therapy Pilot Program Funded By Opioid Settlement Dollars Takes Effect Without Governor’s Signature 56

Congressman And Other Media Outlets Join Marijuana Moment’s Push For DEA To Livestream Rescheduling Hearing 52

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.